Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Insights into atopic dermatitis pathogenesis lead to newly approved systemic therapies
Anna M. Trier, Brian Kim
British Journal of Dermatology (2022) Vol. 188, Iss. 6, pp. 698-708
Open Access | Times Cited: 20

Showing 20 citing articles:

Anti-Inflammatory Effects of Cannabigerol In Vitro and In Vivo Are Mediated Through the JAK/STAT/NFκB Signaling Pathway
Ga Hee Jeong, Ki-Chan Kim, Ji Hyun Lee
Cells (2025) Vol. 14, Iss. 2, pp. 83-83
Open Access | Times Cited: 1
Molecular mechanisms of pruritus in prurigo nodularis
Yixin Shao, Duoqin Wang, Yiqi Zhu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
Beyond the classic players: Mas‐related G protein‐coupled receptor member X2 role in pruritus and skin diseases
Mukesh Kumar, Ye Gi Choi, Trevor K. Wong, et al.
Journal of the European Academy of Dermatology and Venereology (2024)
Open Access | Times Cited: 5
The AhR-Ovol1-Id1 regulatory axis in keratinocytes promotes epidermal and immune homeostasis in atopic dermatitis-like skin inflammation
Zeyu Chen, Morgan Dragan, Peng Sun, et al.
Cellular and Molecular Immunology (2025)
Open Access
Off-Label Treatment in Inflammatory Skin Diseases—European Point of View
Julia Sternicka, Roman Nowicki, Leszek Bieniaszewski, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 7, pp. 2376-2376
Open Access
Novel Therapeutic Targets for the Treatment of Atopic Dermatitis
Gaku Tsuji, Kazuhiko Yamamura, Koji Kawamura, et al.
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1303-1303
Open Access | Times Cited: 12
Heterogeneous IL-9 Production by Circulating Skin-Tropic and Extracutaneous Memory T Cells in Atopic Dermatitis Patients
Irene García‐Jiménez, Lídia Sans‐de San Nicolàs, Laia Curto‐Barredo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8569-8569
Open Access | Times Cited: 4
Emerging Systemic Treatment Options in Atopic Dermatitis
Andaç Salman, Ana M. Giménez‐Arnau
Balkan Medical Journal (2024), pp. 239-247
Open Access | Times Cited: 3
CLA+ memory T cells in atopic dermatitis
Lídia Sans‐de San Nicolàs, Tali Czarnowicki, Mübeccel Akdiş, et al.
Allergy (2023) Vol. 79, Iss. 1, pp. 15-25
Open Access | Times Cited: 8
Biology of Interleukin-17 and Novel Therapies for Hidradenitis Suppurativa
Robert Sabat, Jóhann E. Guðjónsson, Nicolò Costantino Brembilla, et al.
Journal of Interferon & Cytokine Research (2023) Vol. 43, Iss. 12, pp. 544-556
Closed Access | Times Cited: 8
An AhR-Ovol1-Id1 regulatory axis in keratinocytes promotes skin homeostasis against atopic dermatitis
Zeyu Chen, Morgan Dragan, Peng Sun, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Silk Fibroin Formed Bioadhesive Ophthalmic Gel for Dry Eye Syndrome Treatment
Tianjiao Hao, Lu Tang, Qianzi Xu, et al.
AAPS PharmSciTech (2024) Vol. 25, Iss. 5
Closed Access | Times Cited: 2
Cytokine profile of the stratum corneum in atopic dermatitis lesions differs between the face and the trunk
Makiko Kido‐Nakahara, Takahito Chiba, Yuta Mizusawa, et al.
Allergology International (2024)
Open Access | Times Cited: 2
Allergen sensitization stratifies IL-31 production by memory T cells in atopic dermatitis patients
Lídia Sans‐de San Nicolàs, Ignasi Figueras‐Nart, Irene García‐Jiménez, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Esculentoside A ameliorates DNCB‐induced atopic dermatitis by suppressing the ROS‐NLRP3 axis via activating the Nrf2 pathway
Tao Liu, Yuanmin He, Yongmei Liao
Clinical and Experimental Pharmacology and Physiology (2023) Vol. 50, Iss. 11, pp. 844-854
Closed Access | Times Cited: 6
Type 2 cytokine-JAK1 signaling is involved in the development of dry-skin induced mechanical alloknesis
Yui Toyosawa, Eriko Komiya, Takahide Kaneko, et al.
Journal of Dermatological Science (2024)
Closed Access | Times Cited: 1
Atopic dermatitis in 2023 and beyond
Aaron M. Drucker
British Journal of Dermatology (2023) Vol. 188, Iss. 6, pp. 691-692
Open Access | Times Cited: 2
Differentially Expressed Genes in Atopic Dermatitis: Bioinformatics analysis of pooled microarray gene expression datasets in Gene Expression Omnibus
D. Jia, Wenqiang Chen, Li Bin
Journal of Education Health and Sport (2024) Vol. 63, pp. 182-202
Open Access
A Novel Signature for Distinguishing Non-lesional from Lesional Skin of Atopic Dermatitis Based on a Machine Learning Approach
Ana Duarte, Orlando Belo
IFIP advances in information and communication technology (2024), pp. 3-16
Closed Access
Efficacy and anti-inflammatory properties of low-molecular-weight fucoidan in patients with atopic dermatitis: a randomized double-blinded placebo-controlled trial
Huei-Ling Shih, Pin-Han Wang, I‐Hsin Shih, et al.
International Journal of Food Properties (2023) Vol. 27, Iss. 1, pp. 88-105
Open Access | Times Cited: 1
Page 1

Scroll to top